{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:35:56Z","timestamp":1787027756038,"version":"build-2736575974"},"reference-count":79,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2023,1,31]],"date-time":"2023-01-31T00:00:00Z","timestamp":1675123200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007388","name":"Compagnia di San Paolo","doi-asserted-by":"publisher","award":["20067"],"award-info":[{"award-number":["20067"]}],"id":[{"id":"10.13039\/100007388","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007388","name":"Compagnia di San Paolo","doi-asserted-by":"publisher","award":["5 \u00d7 1000 funds 2018\u20132019"],"award-info":[{"award-number":["5 \u00d7 1000 funds 2018\u20132019"]}],"id":[{"id":"10.13039\/100007388","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007388","name":"Compagnia di San Paolo","doi-asserted-by":"publisher","award":["5 \u00d7 1000 funds 2016"],"award-info":[{"award-number":["5 \u00d7 1000 funds 2016"]}],"id":[{"id":"10.13039\/100007388","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007388","name":"Compagnia di San Paolo","doi-asserted-by":"publisher","award":["RC 2022"],"award-info":[{"award-number":["RC 2022"]}],"id":[{"id":"10.13039\/100007388","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007388","name":"Compagnia di San Paolo","doi-asserted-by":"publisher","award":["ACC 2021"],"award-info":[{"award-number":["ACC 2021"]}],"id":[{"id":"10.13039\/100007388","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003196","name":"Italian Ministry of Health","doi-asserted-by":"publisher","award":["20067"],"award-info":[{"award-number":["20067"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003196","name":"Italian Ministry of Health","doi-asserted-by":"publisher","award":["5 \u00d7 1000 funds 2018\u20132019"],"award-info":[{"award-number":["5 \u00d7 1000 funds 2018\u20132019"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003196","name":"Italian Ministry of Health","doi-asserted-by":"publisher","award":["5 \u00d7 1000 funds 2016"],"award-info":[{"award-number":["5 \u00d7 1000 funds 2016"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003196","name":"Italian Ministry of Health","doi-asserted-by":"publisher","award":["RC 2022"],"award-info":[{"award-number":["RC 2022"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003196","name":"Italian Ministry of Health","doi-asserted-by":"publisher","award":["ACC 2021"],"award-info":[{"award-number":["ACC 2021"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"name":"ACC progetto di Rete","award":["20067"],"award-info":[{"award-number":["20067"]}]},{"name":"ACC progetto di Rete","award":["5 \u00d7 1000 funds 2018\u20132019"],"award-info":[{"award-number":["5 \u00d7 1000 funds 2018\u20132019"]}]},{"name":"ACC progetto di Rete","award":["5 \u00d7 1000 funds 2016"],"award-info":[{"award-number":["5 \u00d7 1000 funds 2016"]}]},{"name":"ACC progetto di Rete","award":["RC 2022"],"award-info":[{"award-number":["RC 2022"]}]},{"name":"ACC progetto di Rete","award":["ACC 2021"],"award-info":[{"award-number":["ACC 2021"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Background: Metastatic uveal melanoma (MUM) is a highly aggressive, therapy-resistant disease. Driver mutations in G\u03b1-proteins GNAQ and GNA11 activate MAP-kinase and YAP\/TAZ pathways of oncogenic signalling. MAP-kinase and MEK-inhibitors do not significantly block MUM progression, likely due to persisting YAP\/TAZ signalling. Statins inhibit YAP\/TAZ activation by blocking the mevalonate pathway, geranyl-geranylation, and subcellular localisation of the Rho-GTPase. We investigated drugs that affect the YAP\/TAZ pathway, valproic acid, verteporfin and statins, in combination with MEK-inhibitor trametinib. Methods: We established IC50 values of the individual drugs and monitored the effects of their combinations in terms of proliferation. We selected trametinib and cerivastatin for evaluation of cell cycle and apoptosis. Synergism was detected using isobologram and Chou\u2013Talalay analyses. The most synergistic combination was tested in vivo. Results: Synergistic concentrations of trametinib and cerivastatin induced a massive arrest of proliferation and cell cycle and enhanced apoptosis, particularly in the monosomic, BAP1-mutated UPMM3 cell line. The combined treatment reduced ERK and AKT phosphorylation, increased the inactive, cytoplasmatic form of YAP and significantly impaired the growth of UM cells with monosomy of chromosome 3 in NSG mice. Conclusion: Statins can potentiate the efficacy of MEK inhibitors in the therapy of UM.<\/jats:p>","DOI":"10.3390\/cancers15030886","type":"journal-article","created":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T05:33:53Z","timestamp":1675229633000},"page":"886","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Cerivastatin Synergizes with Trametinib and Enhances Its Efficacy in the Therapy of Uveal Melanoma"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1573-7756","authenticated-orcid":false,"given":"Adriana Agnese","family":"Amaro","sequence":"first","affiliation":[{"name":"IRCCS Ospedale Policlinico San Martino, 16132 Genova, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosaria","family":"Gangemi","sequence":"additional","affiliation":[{"name":"IRCCS Ospedale Policlinico San Martino, 16132 Genova, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5199-6384","authenticated-orcid":false,"given":"Laura","family":"Emionite","sequence":"additional","affiliation":[{"name":"IRCCS Ospedale Policlinico San Martino, 16132 Genova, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2008-9199","authenticated-orcid":false,"given":"Patrizio","family":"Castagnola","sequence":"additional","affiliation":[{"name":"IRCCS Ospedale Policlinico San Martino, 16132 Genova, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6445-8414","authenticated-orcid":false,"given":"Gilberto","family":"Filaci","sequence":"additional","affiliation":[{"name":"IRCCS Ospedale Policlinico San Martino, 16132 Genova, Italy"},{"name":"Centre of Excellence for Biomedical Research, Department of Internal Medicine, University of Genoa, 16132 Genova, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2261-3820","authenticated-orcid":false,"given":"Martine J.","family":"Jager","sequence":"additional","affiliation":[{"name":"Leiden University Medical Center, 2333 ZA Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrica Teresa","family":"Tanda","sequence":"additional","affiliation":[{"name":"IRCCS Ospedale Policlinico San Martino, 16132 Genova, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Spagnolo","sequence":"additional","affiliation":[{"name":"IRCCS Ospedale Policlinico San Martino, 16132 Genova, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Mascherini","sequence":"additional","affiliation":[{"name":"IRCCS Ospedale Policlinico San Martino, 16132 Genova, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0872-4671","authenticated-orcid":false,"given":"Ulrich","family":"Pfeffer","sequence":"additional","affiliation":[{"name":"IRCCS Ospedale Policlinico San Martino, 16132 Genova, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4683-4951","authenticated-orcid":false,"given":"Michela","family":"Croce","sequence":"additional","affiliation":[{"name":"IRCCS Ospedale Policlinico San Martino, 16132 Genova, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,1,31]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/s41572-020-0158-0","article-title":"Uveal Melanoma","volume":"6","author":"Jager","year":"2020","journal-title":"Nat. Rev. Dis. Prim."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.ccell.2017.07.003","article-title":"Integrative Analysis Identifies Four Molecular and Clinical Subsets in Uveal Melanoma","volume":"32","author":"Robertson","year":"2017","journal-title":"Cancer Cell"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/s41467-017-02428-w","article-title":"Punctuated Evolution of Canonical Genomic Aberrations in Uveal Melanoma","volume":"9","author":"Field","year":"2018","journal-title":"Nat. Commun."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"4624","DOI":"10.18632\/oncotarget.6614","article-title":"Deep Sequencing of Uveal Melanoma Identifies a Recurrent Mutation in PLCB4","volume":"7","author":"Johansson","year":"2016","journal-title":"Oncotarget"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1111\/pcmr.12459","article-title":"The Genomic Landscape of Cutaneous Melanoma","volume":"29","author":"Zhang","year":"2016","journal-title":"Pigment. Cell Melanoma Res."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1056\/NEJMoa1000584","article-title":"Mutations in GNA11 in Uveal Melanoma","volume":"363","author":"Griewank","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/nature07586","article-title":"Frequent Somatic Mutations of GNAQ in Uveal Melanoma and Blue Naevi","volume":"457","author":"Bezrookove","year":"2009","journal-title":"Nature"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1126\/science.1194472","article-title":"Frequent Mutation of BAP1 in Metastasizing Uveal Melanomas","volume":"330","author":"Harbour","year":"2010","journal-title":"Science"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Piaggio, F., Tozzo, V., Bernardi, C., Croce, M., Puzone, R., Viaggi, S., Patrone, S., Barla, A., Coviello, D., and Jager, M.J. (2019). Secondary Somatic Mutations in G-Protein-Related Pathways and Mutation Signatures in Uveal Melanoma. Cancers, 11.","DOI":"10.3390\/cancers11111688"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ejca.2022.04.013","article-title":"In Uveal Melanoma G\u03b1-Protein GNA11 Mutations Convey a Shorter Disease-Specific Survival and Are More Strongly Associated with Loss of BAP1 and Chromosomal Alterations than G\u03b1-Protein GNAQ Mutations","volume":"170","author":"Piaggio","year":"2022","journal-title":"Eur. J. Cancer"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Croce, M., Ferrini, S., Pfeffer, U., and Gangemi, R. (2019). Targeted Therapy of Uveal Melanoma: Recent Failures and New Perspectives. Cancers, 11.","DOI":"10.3390\/cancers11060846"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"3526","DOI":"10.1016\/j.molcel.2021.06.020","article-title":"BAP1 Enhances Polycomb Repression by Counteracting Widespread H2AK119ub1 Deposition and Chromatin Condensation","volume":"81","author":"Conway","year":"2021","journal-title":"Mol. Cell"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"5402","DOI":"10.1038\/s41467-021-25529-z","article-title":"Loss of Polycomb Repressive Complex 1 Activity and Chromosomal Instability Drive Uveal Melanoma Progression","volume":"12","author":"Bakhoum","year":"2021","journal-title":"Nat. Commun."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.ceb.2014.01.005","article-title":"Novel Insights into G Protein and G Protein-Coupled Receptor Signaling in Cancer","volume":"27","author":"Degese","year":"2014","journal-title":"Curr. Opin. Cell Biol."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Rossi, E., Croce, M., Reggiani, F., Schinzari, G., Ambrosio, M., Gangemi, R., Tortora, G., Pfeffer, U., and Amaro, A. (2021). Uveal Melanoma Metastasis. Cancers, 13.","DOI":"10.20944\/preprints202110.0013.v1"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"10997","DOI":"10.18632\/oncotarget.2815","article-title":"Oncotargeting G Proteins: The Hippo in the Room","volume":"5","author":"Feng","year":"2014","journal-title":"Oncotarget"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"480","DOI":"10.18632\/oncoscience.57","article-title":"YAP as Oncotarget in Uveal Melanoma","volume":"1","author":"Yu","year":"2014","journal-title":"Oncoscience"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1101\/gad.262816.115","article-title":"A YAP\/TAZ-Induced Feedback Mechanism Regulates Hippo Pathway Homeostasis","volume":"29","author":"Moroishi","year":"2015","journal-title":"Genes Dev."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"E3729","DOI":"10.1073\/pnas.1703096114","article-title":"Hippo Pathway Mediates Resistance to Cytotoxic Drugs","volume":"114","author":"Gujral","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1038\/ng.3218","article-title":"The Hippo Effector YAP Promotes Resistance to RAF- and MEK-Targeted Cancer Therapies","volume":"47","author":"Lin","year":"2015","journal-title":"Nat. Genet."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/s41598-017-18527-z","article-title":"Enhanced YAP Expression Leads to EGFR TKI Resistance in Lung Adenocarcinomas","volume":"8","author":"Lee","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"17848","DOI":"10.1073\/pnas.1908228116","article-title":"Cell Phenotypic Plasticity Requires Autophagic Flux Driven by YAP\/TAZ Mechanotransduction","volume":"116","author":"Totaro","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1038\/ncb2303","article-title":"The Hippo Pathway in Organ Size Control, Tissue Regeneration and Stem Cell Self-Renewal","volume":"13","author":"Zhao","year":"2011","journal-title":"Nat. Cell Biol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"6793","DOI":"10.21037\/apm-21-1243","article-title":"A Systematic Review and Meta-Analysis on the Efficacy of Statins in the Treatment of Atherosclerosis","volume":"10","author":"Jia","year":"2021","journal-title":"Ann. Palliat. Med."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1158\/0008-5472.CAN-17-1231","article-title":"Statin-Induced Cancer Cell Death Can Be Mechanistically Uncoupled from Prenylation of RAS Family Proteins","volume":"78","author":"Yu","year":"2018","journal-title":"Cancer Res."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"626971","DOI":"10.3389\/fonc.2021.626971","article-title":"The Mevalonate Pathway, a Metabolic Target in Cancer Therapy","volume":"11","author":"Guerra","year":"2021","journal-title":"Front. Oncol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/ncb2936","article-title":"Metabolic Control of YAP and TAZ by the Mevalonate Pathway","volume":"16","author":"Sorrentino","year":"2014","journal-title":"Nat. Cell Biol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1016\/j.jid.2020.12.015","article-title":"Computational Drug Repositioning Identifies Statins as Modifiers of Prognostic Genetic Expression Signatures and Metastatic Behavior in Melanoma","volume":"141","author":"Yu","year":"2021","journal-title":"J. Invest. Dermatol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1167\/iovs.62.4.3","article-title":"Targeting the YAP\/TAZ Pathway in Uveal and Conjunctival Melanoma With Verteporfin","volume":"62","author":"Brouwer","year":"2021","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Palamaris, K., Moutafi, M., Gakiopoulou, H., and Theocharis, S. (2022). Histone Deacetylase (HDAC) Inhibitors: A Promising Weapon to Tackle Therapy Resistance in Melanoma. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23073660"},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Goutas, D., Theocharis, S., and Tsourouflis, G. (2021). Unraveling the Epigenetic Role and Clinical Impact of Histone Deacetylases in Neoplasia. Diagnostics, 11.","DOI":"10.3390\/diagnostics11081346"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1038\/s41417-022-00443-8","article-title":"New Targeted and Epigenetic Therapeutic Strategies for the Treatment of Uveal Melanoma","volume":"29","author":"Wei","year":"2022","journal-title":"Cancer Gene Ther."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1158\/1078-0432.CCR-11-0946","article-title":"Histone Deacetylase Inhibitors Induce Growth Arrest and Differentiation in Uveal Melanoma","volume":"18","author":"Landreville","year":"2012","journal-title":"Clin. Cancer Res."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/ijc.2910620208","article-title":"Establishment and Characterization of an Uveal-Melanoma Cell Line","volume":"62","author":"Blom","year":"1995","journal-title":"Int. J. Cancer"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1097\/00002371-199707000-00003","article-title":"Expression of MAGE Genes in Ocular Melanoma Cell Lines","volume":"20","author":"Chen","year":"1997","journal-title":"J. Immunother."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1002\/(SICI)1097-0215(19960503)66:3<380::AID-IJC19>3.0.CO;2-F","article-title":"Establishment and Characterization of Primary and Metastatic Uveal Melanoma Cell Lines","volume":"66","author":"Luyten","year":"1996","journal-title":"Int. J. Cancer"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1002\/(SICI)1097-0215(19971114)73:4<470::AID-IJC3>3.0.CO;2-X","article-title":"Melanomas That Develop within the Eye Inhibit Lymphocyte Proliferation","volume":"73","author":"Verbik","year":"1997","journal-title":"Int. J. Cancer"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1159\/000201566","article-title":"Novel Cell Lines Derived by Long-Term Culture of Primary Uveal Melanomas","volume":"223","author":"Nareyeck","year":"2009","journal-title":"Ophthalmologica"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0065-2571(84)90007-4","article-title":"Quantitative Analysis of Dose-Effect Relationships: The Combined Effects of Multiple Drugs or Enzyme Inhibitors","volume":"22","author":"Chou","year":"1984","journal-title":"Adv. Enzym. Regul."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1111\/pcmr.12306","article-title":"ADAM10 Correlates with Uveal Melanoma Metastasis and Promotes in Vitro Invasion","volume":"27","author":"Gangemi","year":"2014","journal-title":"Pigment. Cell Melanoma Res."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1093\/biostatistics\/4.2.249","article-title":"Exploration, Normalization, and Summaries of High Density Oligonucleotide Array Probe Level Data","volume":"4","author":"Irizarry","year":"2003","journal-title":"Biostatistics"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"5116","DOI":"10.1073\/pnas.091062498","article-title":"Significance Analysis of Microarrays Applied to the Ionizing Radiation Response","volume":"98","author":"Tusher","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"3353","DOI":"10.1016\/j.ejca.2013.06.011","article-title":"Evidence of Epidermal Growth Factor Receptor Expression in Uveal Melanoma: Inhibition of Epidermal Growth Factor-Mediated Signalling by Gefitinib and Cetuximab Triggered Antibody-Dependent Cellular Cytotoxicity","volume":"49","author":"Amaro","year":"2013","journal-title":"Eur. J. Cancer"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1101\/gad.192856.112","article-title":"Genetic and Pharmacological Disruption of the TEAD-YAP Complex Suppresses the Oncogenic Activity of YAP","volume":"26","author":"Huang","year":"2012","journal-title":"Genes Dev."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"5686","DOI":"10.1158\/1078-0432.CCR-18-3382","article-title":"HDAC Inhibition Enhances the In Vivo Efficacy of MEK Inhibitor Therapy in Uveal Melanoma","volume":"25","author":"Emmons","year":"2019","journal-title":"Clin. Cancer Res."},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Mergener, S., Siveke, J.T., and Pe\u00f1a-Llopis, S. (2021). Monosomy 3 Is Linked to Resistance to MEK Inhibitors in Uveal Melanoma. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22136727"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"44219","DOI":"10.1038\/srep44219","article-title":"Variability in Statin-Induced Changes in Gene Expression Profiles of Pancreatic Cancer","volume":"7","author":"Ruml","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1016\/j.celrep.2017.05.014","article-title":"Cancer-Associated IDH1 Promotes Growth and Resistance to Targeted Therapies in the Absence of Mutation","volume":"19","author":"Calvert","year":"2017","journal-title":"Cell Rep."},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Han, Y., Li, Z., Wu, Q., Liu, H., Sun, Z., Wu, Y., and Luo, J. (2022). B4GALT5 High Expression Associated with Poor Prognosis of Hepatocellular Carcinoma. BMC Cancer, 22.","DOI":"10.1186\/s12885-022-09442-2"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"2901","DOI":"10.1158\/0008-5472.CAN-12-0572","article-title":"The RASSF3 Candidate Tumor Suppressor Induces Apoptosis and G1\u2013S Cell-Cycle Arrest via P53","volume":"72","author":"Kudo","year":"2012","journal-title":"Cancer Res."},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Bin, B.-H., Bhin, J., Yang, S.H., Shin, M., Nam, Y.-J., Choi, D.-H., Shin, D.W., Lee, A.-Y., Hwang, D., and Cho, E.-G. (2015). Membrane-Associated Transporter Protein (MATP) Regulates Melanosomal PH and Influences Tyrosinase Activity. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0129273"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"TPS10086","DOI":"10.1200\/JCO.2020.38.15_suppl.TPS10086","article-title":"A Phase Ib Study of Endogenous SLC45A2-Specific Cytotoxic T Cells for the Treatment of Patients with Metastatic Uveal Melanoma","volume":"38","author":"Phillips","year":"2020","journal-title":"J. Clin. Oncol."},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Rimpelov\u00e1, S., Kol\u00e1\u0159, M., Strnad, H., Ruml, T., V\u00edtek, L., and Gbelcov\u00e1, H. (2021). Comparison of Transcriptomic Profiles of MiaPaCa-2 Pancreatic Cancer Cells Treated with Different Statins. Molecules, 26.","DOI":"10.3390\/molecules26123528"},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Dongoran, R.A., Wang, K.-H., Lin, T.-J., Yuan, T.-C., and Liu, C.-H. (2020). Anti-Proliferative Effect of Statins Is Mediated by DNMT1 Inhibition and P21 Expression in OSCC Cells. Cancers, 12.","DOI":"10.3390\/cancers12082084"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"2628","DOI":"10.1093\/bioinformatics\/btz931","article-title":"ShinyGO: A Graphical Gene-Set Enrichment Tool for Animals and Plants","volume":"36","author":"Ge","year":"2020","journal-title":"Bioinformatics"},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Marseglia, M., Amaro, A., Solari, N., Gangemi, R., Croce, E., Tanda, E.T., Spagnolo, F., Filaci, G., Pfeffer, U., and Croce, M. (2021). How to Make Immunotherapy an Effective Therapeutic Choice for Uveal Melanoma. Cancers, 13.","DOI":"10.3390\/cancers13092043"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/j.ccr.2014.04.017","article-title":"Mutant Gq\/11 Promote Uveal Melanoma Tumorigenesis by Activating YAP","volume":"25","author":"Yu","year":"2014","journal-title":"Cancer Cell"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1158\/1078-0432.CCR-20-4530","article-title":"MEK-Ing the Most of It: Strategies to Co-Target G\u03b1q and MAPK in Uveal Melanoma","volume":"27","author":"Smalley","year":"2021","journal-title":"Clin. Cancer Res."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"139","DOI":"10.2165\/00002512-200016020-00005","article-title":"Verteporfin","volume":"16","author":"Scott","year":"2000","journal-title":"Drugs Aging"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.bioactmat.2022.01.028","article-title":"Verteporfin-Mediated on\/off Photoswitching Functions Synergistically to Treat Choroidal Vascular Diseases","volume":"14","author":"Ju","year":"2022","journal-title":"Bioact. Mater."},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Souri, Z., Jochemsen, A.G., Versluis, M., Wierenga, A.P.A., Nemati, F., van der Velden, P.A., Kroes, W.G.M., Verdijk, R.M., Luyten, G.P.M., and Jager, M.J. (2020). HDAC Inhibition Increases HLA Class I Expression in Uveal Melanoma. Cancers, 12.","DOI":"10.3390\/cancers12123690"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1158\/1541-7786.MCR-20-0434","article-title":"Dual Screen for Efficacy and Toxicity Identifies HDAC Inhibitor with Distinctive Activity Spectrum for BAP1-Mutant Uveal Melanoma","volume":"19","author":"Kuznetsoff","year":"2021","journal-title":"Mol. Cancer Res."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"e22059","DOI":"10.1200\/JCO.2020.38.15_suppl.e22059","article-title":"A Randomized Phase II Study of Adjuvant Sunitinib or Valproic Acid in High-Risk Patients with Uveal Melanoma","volume":"38","author":"Sato","year":"2020","journal-title":"J. Clin. Oncol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1186\/s13046-021-02041-2","article-title":"Statins: A Repurposed Drug to Fight Cancer","volume":"40","author":"Jiang","year":"2021","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"e10581","DOI":"10.15252\/emmm.201910581","article-title":"Targeting YAP to Overcome Acquired Resistance to ALK Inhibitors in ALK-Rearranged Lung Cancer","volume":"11","author":"Yun","year":"2019","journal-title":"EMBO Mol. Med."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/cbdd.13762","article-title":"Identification of Potential Modulators of Osteosarcoma Metastasis by High-Throughput Cellular Screening of Natural Products","volume":"97","author":"Long","year":"2021","journal-title":"Chem. Biol. Drug Des."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.amjcard.2005.08.002","article-title":"Reducing Residual Risk for Patients on Statin Therapy: The Potential Role of Combination Therapy","volume":"96","author":"Davidson","year":"2005","journal-title":"Am. J. Cardiol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1111\/pcmr.12849","article-title":"Decitabine Limits Escape from MEK Inhibition in Uveal Melanoma","volume":"33","author":"Emmons","year":"2020","journal-title":"Pigment. Cell Melanoma Res."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1158\/1541-7786.MCR-10-0437","article-title":"Status of RASSF1A in Uveal Melanocytes and Melanoma Cells","volume":"9","author":"Calipel","year":"2011","journal-title":"Mol. Cancer Res."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"196715","DOI":"10.1155\/2012\/196715","article-title":"The SARAH Domain of RASSF1A and Its Tumor Suppressor Function","volume":"2012","author":"Dittfeld","year":"2012","journal-title":"Mol. Biol. Int."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/2045-3701-3-31","article-title":"Mst1 and Mst2 Kinases: Regulations and Diseases","volume":"3","author":"Qin","year":"2013","journal-title":"Cell Biosci."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.gendis.2019.11.003","article-title":"The Hippo Tumor Suppressor Pathway (YAP\/TAZ\/TEAD\/MST\/LATS) and EGFR-RAS-RAF-MEK in Cancer Metastasis","volume":"8","author":"Zinatizadeh","year":"2021","journal-title":"Genes Dis."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1186\/CVM-2-5-205","article-title":"Withdrawal of Cerivastatin from the World Market","volume":"2","author":"Furberg","year":"2001","journal-title":"Curr. Control. Trials Cardiovasc. Med."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1056\/NEJM200202143460721","article-title":"Cerivastatin and Reports of Fatal Rhabdomyolysis","volume":"346","author":"Staffa","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1254\/jphs.13R06CP","article-title":"Mechanism of Statin-Induced Rhabdomyolysis","volume":"123","author":"Sakamoto","year":"2013","journal-title":"J. Pharmacol. Sci."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.bbrc.2015.09.065","article-title":"Skeletal Muscle-Specific HMG-CoA Reductase Knockout Mice Exhibit Rhabdomyolysis: A Model for Statin-Induced Myopathy","volume":"466","author":"Osaki","year":"2015","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_77","first-page":"CD012501","article-title":"Cerivastatin for Lowering Lipids","volume":"1","author":"Adams","year":"2020","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1002\/cpt.2557","article-title":"The Clinical Pharmacogenetics Implementation Consortium Guideline for SLCO1B1, ABCG2, and CYP2C9 Genotypes and Statin-Associated Musculoskeletal Symptoms","volume":"111","author":"Niemi","year":"2022","journal-title":"Clin. Pharmacol. Ther."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.amjmed.2006.02.007","article-title":"Clinical Perspectives of Statin-Induced Rhabdomyolysis","volume":"119","author":"Antons","year":"2006","journal-title":"Am. J. Med."}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/15\/3\/886\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T18:19:33Z","timestamp":1760120373000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/15\/3\/886"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,31]]},"references-count":79,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2023,2]]}},"alternative-id":["cancers15030886"],"URL":"https:\/\/doi.org\/10.3390\/cancers15030886","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,31]]}}}